INT45111

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.58
First Reported 1983
Last Reported 2010
Negated 0
Speculated 1
Reported most in Body
Documents 15
Total Number 16
Disease Relevance 4.16
Pain Relevance 0.47

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular region (PRB1) molecular_function (PRB1) biological_process (PRB1)
Anatomy Link Frequency
neural 1
PRB1 (Homo sapiens)
Pain Link Frequency Relevance Heat
fibrosis 7 100.00 Very High Very High Very High
iatrogenic 8 82.40 Quite High
dexamethasone 5 76.52 Quite High
methadone 1 53.52 Quite High
addiction 1 52.48 Quite High
Angina 27 36.96 Quite Low
Paracetamol 4 16.92 Low Low
cytokine 16 16.80 Low Low
Potency 7 5.00 Very Low Very Low Very Low
cva 6 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Myelodysplastic Syndromes 18 100.00 Very High Very High Very High
Myelofibrosis 10 100.00 Very High Very High Very High
Fibrosis 6 100.00 Very High Very High Very High
Myeloproliferative Disorder 12 99.78 Very High Very High Very High
Sprains And Strains 1 89.76 High High
Acquired Immune Deficiency Syndrome Or Hiv Infection 118 89.04 High High
Disease 104 83.28 Quite High
Pneumothorax 8 82.92 Quite High
Emergencies 95 79.84 Quite High
Multiple Myeloma 24 77.80 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
We conclude that massive granulomatous lesions with the radiographic appearance of PMF can occur in association with intravenous injection of talc.
Gene_expression (appearance) of PMF associated with fibrosis
1) Confidence 0.58 Published 1983 Journal Am. J. Clin. Pathol. Section Abstract Doc Link 6624719 Disease Relevance 0.54 Pain Relevance 0.23
Using the data from the whole pheromone study (618% labeling above background) and the data from the two present studies, we find that PRF and PMF together (330% + 124% = 454% labeling above background) produce neural labeling that is 73.5% of that produced by whole pheromone (454% / 618% = 73.5%).
Gene_expression (produce) of PMF in neural
2) Confidence 0.26 Published 2006 Journal BMC Neurosci Section Body Doc Link PMC1550415 Disease Relevance 0 Pain Relevance 0
When expressed as a percentage of control numbers, whole pheromone (containing both PRF and PMF) produced labeling 618% above control levels while PRF produced 330% labeling and PMF produced 124% labeling above the respective control group levels.
Gene_expression (produced) of PMF
3) Confidence 0.20 Published 2006 Journal BMC Neurosci Section Body Doc Link PMC1550415 Disease Relevance 0 Pain Relevance 0
The PMS were dissatisfied because they have had to make repeated visits to health centres before they could replenish their stock as the health workers were either not at their posts or they have closed before CMDs get to the health centre.
Gene_expression (dissatisfied) of PMS
4) Confidence 0.11 Published 2008 Journal BMC Health Serv Res Section Body Doc Link PMC2429909 Disease Relevance 0.05 Pain Relevance 0
The identification of an acquired somatic mutation in the JAK2 gene, resulting in a valine to phenylalanine substitution at position 617 (JAK2-V617F), has provided new insights into the pathogenesis of BCR-ABL1-negative MPN, which is found in most patients with polycythemia vera (PV) and in about 50% of patients with essential thrombocythemia (ET) and PMF [98, 99].
Spec (found) Gene_expression (found) of PMF associated with myeloproliferative disorder, myelodysplastic syndromes and myelofibrosis
5) Confidence 0.07 Published 2010 Journal Journal of Oncology Section Body Doc Link PMC2875768 Disease Relevance 1.41 Pain Relevance 0.16
A survey of physicians and device companies estimated that 153,000 PMs and 29,000 AICDs were implanted in 1997.5 Our administrative data-based estimates for the same year were 145,000 PMs and 27,000 AICDs, suggesting that administrative data are an alternative to assessment of cardiac device utilization in the United States.
Gene_expression (implanted) of PMs
6) Confidence 0.06 Published 2007 Journal J Gen Intern Med Section Body Doc Link PMC2359586 Disease Relevance 0.46 Pain Relevance 0.04
A survey of physicians and device companies estimated that 153,000 PMs and 29,000 AICDs were implanted in 1997.5 Our administrative data-based estimates for the same year were 145,000 PMs and 27,000 AICDs, suggesting that administrative data are an alternative to assessment of cardiac device utilization in the United States.
Gene_expression (implanted) of PMs
7) Confidence 0.06 Published 2007 Journal J Gen Intern Med Section Body Doc Link PMC2359586 Disease Relevance 0.43 Pain Relevance 0.04
where pmkt represents levels of PM10, tempt?
Gene_expression (levels) of PM10
8) Confidence 0.04 Published 2006 Journal Environ Health Perspect Section Body Doc Link PMC1665419 Disease Relevance 0 Pain Relevance 0
Temperature effects were modified by levels of PM10 for RHA, REV, NEMC, and CM, less so for CHA and CEV.
Gene_expression (levels) of PM10
9) Confidence 0.03 Published 2006 Journal Environ Health Perspect Section Body Doc Link PMC1665419 Disease Relevance 0 Pain Relevance 0
For most lags and most health outcomes, the percent changes were higher when PM10 levels were higher.
Gene_expression (levels) of PM10
10) Confidence 0.03 Published 2006 Journal Environ Health Perspect Section Body Doc Link PMC1665419 Disease Relevance 0 Pain Relevance 0
The temperature effects were more adverse at high levels of PM10.
Gene_expression (levels) of PM10
11) Confidence 0.03 Published 2006 Journal Environ Health Perspect Section Body Doc Link PMC1665419 Disease Relevance 0.08 Pain Relevance 0
We used a stratification model quantitatively to assess the associations of temperature with health outcomes across PM10 levels by including an interaction term of temperature and PM10 in which PM10 was categorized into two levels.
Gene_expression (levels) of PM10
12) Confidence 0.03 Published 2006 Journal Environ Health Perspect Section Body Doc Link PMC1665419 Disease Relevance 0.24 Pain Relevance 0
Because the estimated effects of temperature variability differed with PM10 levels, we present the estimated coefficients of model 3 instead of relative risks (Table 2).
Gene_expression (levels) of PM10
13) Confidence 0.03 Published 2006 Journal Environ Health Perspect Section Body Doc Link PMC1665419 Disease Relevance 0 Pain Relevance 0
Both the bivariate response surface and nonstratification models suggest that the effects of temperature on cardiorespiratory morbidity/mortality varied with levels of PM10.
Gene_expression (levels) of PM10
14) Confidence 0.03 Published 2006 Journal Environ Health Perspect Section Body Doc Link PMC1665419 Disease Relevance 0 Pain Relevance 0
Median PM10 and PM2.5 levels were higher during the outbreak period than both the same period in earlier years and compared with the whole study period.
Gene_expression (levels) of PM10
15) Confidence 0.01 Published 2007 Journal Environ Health Section Body Doc Link PMC2212623 Disease Relevance 0.20 Pain Relevance 0
The cells were then washed and mixed with RFP-expressing PM-1 indicator cells and analyzed for virus transfer from the A3-CCR5 population to the RFP-positive indicator cell line PM-1.
Gene_expression (expressing) of PM-1
16) Confidence 0.01 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2925957 Disease Relevance 0.73 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox